P2.095 Origins of Repeat Infections with Mycoplasma Genitalium (Mg) Among Heterosexual Men in Two Southern U.S. Cities. (13th July 2013)

• Record Type: Journal Article
• Authors: Kissinger, P; White, S; Schmidt, N; Taylor, S N; Mena, L; Lillis, R; Some, S A; Defayette, K; Martin, D H
• Is Part Of: Sexually transmitted infections. Volume 89(2013)Supplement 1
• Page Start: A117
• Page End: A117
• Publication Date: 2013-07-13
• Subjects: genotyping -- Mycoplasma genitalium -- repeat infections; Sexually transmitted diseases -- Periodicals; HIV infections -- Periodicals; 616.951005
• DOI: 10.1136/sextrans-2013-051184.0359
• Languages: English
• ISSNs: 1368-4973

Abstract

Abstract : Background: The purpose of this study was to examine the origins of repeat infections with Mg among men. High repeat infection rates have been consistently reported and treatment failure secondary to macrolide resistance is thought to be the primary cause. This study adds to the growing literature by describing the possible origins of repeat Mg infections in among men, primarily African American, attending two public STD clinics in southern cities in the U.S. Methods: Men diagnosed with NGU at an STD clinic in New Orleans, Louisiana, and Jackson, Mississippi, were tested for Mg using the GenProbe research-use-only assay Mg+ men underwent a 4–10 week test of cure visit (TOC) following treatment with 1 g azithromycin. Detailed sexual behaviour data were collected at baseline and follow-up via ACASI and genotyping was performed. Results: Of 205 men with MG, 135 returned for TOC visit and of those, 34.3% were positive. Of the 46 who were positive at TOC, 19.6% reported sexual re-exposure to a baseline partner, 6.5% reported sexual exposure to a new partner, 6.5% reported sexual exposure to both, and 67.4% denied sexual re-exposure. Men who re-tested positive for Mg at TOC (n = 46) were no more likely that those who tested negative (n = 88) to have had sexual exposure to a baseline partner (31.8% vs. 26.1%, P = 0.55) or exposure to a new partner (21.4% vs. 11.3%, P = 0.22). Genotyping on baseline/TOC positive pairs is being performed and will be used in conjunction with behavioural data to more precisely estimate the treatment failure rate. Conclusion: The TOC repeat infection rate among men with Mg is high. Our data are consistent with the published literature corroborating that repeat infections in men treated with azithromycin is usually due to treatment failure rather than re-infection. Research is needed to optimise treatment of Mg infections in men.